Enbridge Tour Alberta for Cancer

The Alberta Cancer Foundation’s Enbridge Tour Alberta for Cancer celebrates 15th Anniversary Ride

The Alberta Cancer Foundation’s Enbridge Tour Alberta for Cancer celebrates 15th Anniversary Ride

Over $5.5 million raised for Albertans facing cancer as part of legendary cycling event that supports cancer detection, research and care across Alberta.

July 22, 2023 – Strathmore, AB – Today, over 1,200 cyclists and their supporters are gathering in Strathmore and area for Alberta’s largest cycling fundraiser, the Enbridge Tour Alberta for Cancer in support of the Alberta Cancer Foundation. Throughout the two-day event, cyclists will journey up to 200 kilometres around the beautiful Alberta countryside. The tour is a fun and meaningful way for Albertans to honour those who are facing cancer—our loved ones, our friends, our colleagues and our neighbours. Whether riding as an individual, as part of a corporate or community team, or participating as a volunteer, there is a place for everyone to make an impact.

While each year of the Tour is special for many reasons, this year, the Alberta Cancer Foundation celebrates 15 years of this legendary ride. That is 15 years of community building, 15 years of memories, and 15 years of making life better for all Albertans whose lives have been affected by cancer.

“When I think about the impact this legendary ride has had on our community since its inauguration, I am incredibly touched,” says Wendy Beauchesne, CEO of the Alberta Cancer Foundation. “Over the past 15 years, the tour has contributed over $90 million to cancer research and care across Alberta. We know that kind of impact takes a village, so we are grateful for every rider, donor and partner, including our friends at Enbridge, who have dedicated their time and resources to making a difference for over 23,000 Albertans who hear the words, ‘You have cancer,’ each year.”

Enbridge has supported the cancer fundraiser for a number of years, including as title sponsor since 2010. This year, the company’s dedicated cycling team of 155 participants has raised more than $650,000 to support the Alberta Cancer Foundation.

“We need to continue to come out, to fundraise and support research that will make a difference,” said Max Chan, Senior Vice President and Corporate Development Officer, Enbridge, Rider, and member of Alberta Cancer Foundation’s Board of Trustees. “We’re proud to be the title sponsor of the Tour Alberta, which has an unparalleled impact on cancer outcomes for Albertans.”

All funds raised for the Alberta Cancer Foundation’s Enbridge Tour Alberta for Cancer will support leading-edge cancer research – including ground-breaking clinical trials, patient support programs, and enhanced care at the 17 cancer centres across Alberta. This support will continue to benefit the 1 in 2 Albertans who will face a cancer diagnosis in their lifetime including first time Rider, Mike Zurawell.

“In early November of 2022, I was told, ‘You have cancer’. Three words nobody wants to hear. I had a football sized mass inside of me and was diagnosed with Double Hit Lymphoma, a rare and aggressive type of cancer. I spent 34 nights and underwent extensive chemotherapy as well as 15 rounds of radiation at the Cross Cancer Institute. Let me tell you, everyone there was fantastic. I received a level of care that was phenomenal and I will be eternally grateful for that. I have committed to the Enbridge Tour Alberta Cancer ride as a way I can give back directly to the people and facility who are helping me and other patients through this journey,” says Mike.

Media are invited to join Mike Zurawell and many other inspirational Albertans at this weekend’s tour events.

What: 2023 Enbridge Tour Alberta for Cancer

When: July 22-23, 2023
Opening speeches: 7:30 a.m.
Cyclists depart: 8:00 a.m.

Where: Strathmore Stampede Grounds
33 Wheatland Trail | Strathmore, AB

Highlights: 100km and 70km cycling tour each day
Food, drinks and entertainment
Self-camping

For more information on the tour, to register, or to donate, visit 2023.touralbertaforcancer.ca. You can also access the 2023 Enbridge Tour Alberta for Cancer campaign video and complementary b-roll here.

DOWNLOAD PRESS RELEASE


For media inquiries, contact:

Breanne Kraus
Director, Communications and Marketing
Alberta Cancer Foundation
breanne.kraus@albertacancer.ca | Cell: 780.905.9273

About the Alberta Cancer Foundation

Creating more moments for Albertans facing cancer by inspiring our community to give to innovation in detection, treatment and care.

Albertans helping Albertans is at the core of everything the Alberta Cancer Foundation does. As the official fundraising partner for every Alberta Health Services cancer centre in Alberta, our very purpose comes from our desire to create more moments for all Albertans facing cancer, no matter where they live or the type of cancer they are facing. From the mountains in Canmore to the canola fields in Lloydminster, we make life better for Albertans facing cancer by supporting world-class research and patient care, close to home. Learn more at albertacancer.ca.

About Enbridge Inc.

At Enbridge, we safely connect millions of people to the energy they rely on every day, fueling quality of life through our North American natural gas, oil or renewable power networks and our growing European offshore wind portfolio. We’re investing in modern energy delivery infrastructure to sustain access to secure, affordable energy and building on two decades of experience in renewable energy to advance new technologies including wind and solar power, hydrogen, renewable natural gas and carbon capture and storage. We’re committed to reducing the carbon footprint of the energy we deliver, and to achieving net zero greenhouse gas emissions by

2050. Headquartered in Calgary, Alberta, Enbridge’s common shares trade under the symbol ENB on the Toronto (TSX) and New York (NYSE) stock exchanges. To learn more, visit us at enbridge.com.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.